Weighted Average Number of Shares Outstanding, Basic of ANAVEX LIFE SCIENCES CORP. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ANAVEX LIFE SCIENCES CORP. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • ANAVEX LIFE SCIENCES CORP. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 89,029,458, a 5% increase year-over-year.
  • ANAVEX LIFE SCIENCES CORP. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 85,289,447, a 2.2% increase from 2024.
  • ANAVEX LIFE SCIENCES CORP. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 83,468,049, a 4.6% increase from 2023.
  • ANAVEX LIFE SCIENCES CORP. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 79,787,596, a 3.7% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ANAVEX LIFE SCIENCES CORP. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 89,029,458 +4,223,484 +5% 01 Oct 2025 31 Dec 2025 10-Q 09 Feb 2026 2026 Q1
Q3 2025 85,289,447 +1,821,398 +2.2% 01 Jul 2025 30 Sep 2025 10-K 25 Nov 2025 2025 FY
Q2 2025 85,380,587 +845,259 +1% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 85,073,769 +2,609,543 +3.2% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 84,805,974 +2,728,159 +3.3% 01 Oct 2024 31 Dec 2024 10-Q 09 Feb 2026 2026 Q1
Q3 2024 83,468,049 +3,680,453 +4.6% 01 Jul 2024 30 Sep 2024 10-K 25 Nov 2025 2025 FY
Q2 2024 84,535,328 +3,660,093 +4.5% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q3
Q1 2024 82,464,226 +4,159,863 +5.3% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q2
Q4 2023 82,077,815 +4,100,703 +5.3% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2025 Q1
Q3 2023 79,787,596 01 Jul 2023 30 Sep 2023 10-K 25 Nov 2025 2025 FY
Q2 2023 80,875,235 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q3
Q1 2023 78,304,363 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q2
Q4 2022 77,977,112 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024 2024 Q1
Q1 2017 41,159,707 +5,944,914 +17% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2017 2017 Q2
Q4 2016 38,393,910 +4,421,997 +13% 01 Oct 2016 31 Dec 2016 10-Q 07 Feb 2017 2017 Q1
Q3 2016 35,153,426 +16,568,606 +89% 01 Jul 2016 30 Sep 2016 10-K 14 Dec 2016 2016 FY
Q2 2016 35,709,686 +16,614,631 +87% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2016 2016 Q3
Q1 2016 35,214,793 +20,887,848 +146% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q2
Q4 2015 33,971,913 +21,064,315 +163% 01 Oct 2015 31 Dec 2015 10-Q 07 Feb 2017 2017 Q1
Q3 2015 18,584,820 +8,780,281 +90% 01 Jul 2015 30 Sep 2015 10-K 14 Dec 2016 2016 FY
Q2 2015 19,095,055 -20,165,043 -51% 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q3
Q1 2015 14,326,945 -23,554,264 -62% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q2
Q4 2014 12,907,598 -24,577,195 -66% 01 Oct 2014 31 Dec 2014 10-Q 08 Feb 2016 2016 Q1
Q3 2014 9,804,539 -22,103,902 -69% 01 Jul 2014 30 Sep 2014 10-K 14 Dec 2016 2016 FY
Q2 2014 39,260,098 +9,019,411 +30% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q3
Q1 2014 37,881,209 +7,640,522 +25% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q2
Q4 2013 37,484,793 +7,244,106 +24% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015 2015 Q1
Q3 2013 31,908,441 01 Jul 2013 30 Sep 2013 10-K 29 Dec 2014 2014 FY
Q2 2013 30,240,687 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014 2014 Q3
Q1 2013 30,240,687 01 Jan 2013 31 Mar 2013 10-Q/A 30 May 2014 2014 Q2
Q4 2012 30,240,687 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2014 Q1

ANAVEX LIFE SCIENCES CORP. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 85,289,447 +1,821,398 +2.2% 01 Oct 2024 30 Sep 2025 10-K 25 Nov 2025 2025 FY
2024 83,468,049 +3,680,453 +4.6% 01 Oct 2023 30 Sep 2024 10-K 25 Nov 2025 2025 FY
2023 79,787,596 +2,877,603 +3.7% 01 Oct 2022 30 Sep 2023 10-K 25 Nov 2025 2025 FY
2022 76,909,993 +7,107,033 +10% 01 Oct 2021 30 Sep 2022 10-K 27 Nov 2023 2023 FY
2021 69,802,960 01 Oct 2020 30 Sep 2021 10-K 27 Nov 2023 2023 FY
2016 35,153,426 +16,568,606 +89% 01 Oct 2015 30 Sep 2016 10-K 14 Dec 2016 2016 FY
2015 18,584,820 +8,780,281 +90% 01 Oct 2014 30 Sep 2015 10-K 14 Dec 2016 2016 FY
2014 9,804,539 -22,103,902 -69% 01 Oct 2013 30 Sep 2014 10-K 14 Dec 2016 2016 FY
2013 31,908,441 01 Oct 2012 30 Sep 2013 10-K 29 Dec 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.